CRISPR Therapeutics AG
CRSP- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001674416
In the last 90 days, CRISPR Therapeutics AG insiders filed 0 open-market purchases and 2 sales; 525 institutions reported holding it in 13F filings for Q2 2026, worth $4.16B in total; ARK Invest is the only superinvestor holding it.
Holders of 5% or more of CRSP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of CRISPR Therapeutics AG, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 13G/A | 11.79%11.3M shares | +1.03 ppfrom 10.76% | Jan 10, 20255 filings | Apr 30, 2026 | SEC |
| BlackRock, Inc. | 13G | 6.90%5.93M shares | New | Jul 17, 20251 filing | Jul 17, 2025 | SEC |
| Orbis Investment Management Ltd | 13G/A | 6.30%6.09M shares | +0.10 ppfrom 6.20% | Nov 14, 20253 filings | May 15, 2026 | SEC |
| Capital World Investors | 13G | 5.10%4.93M shares | New | May 14, 20261 filing | May 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on CRISPR Therapeutics AG, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 202612:59 PM ET | Orbis Investment Management Ltdand 1 other | 13G/A | 6.30%6.09M shares | +0.10 ppfrom 6.20% | Mar 31, 2026 | SEC |
| May 14, 20261:55 PM ET | Capital World Investors | 13G | 5.10%4.93M shares | New | Mar 31, 2026 | SEC |
| Apr 30, 202612:41 PM ET | ARK Investment Management LLCand 1 otherSuperinvestorARK Invest | 13G/A | 11.79%11.3M shares | +1.03 ppfrom 10.76% | Mar 31, 2026 | SEC |
| Feb 17, 202612:06 PM ET | Orbis Investment Management Ltdand 1 other | 13G/A | 6.20%5.93M shares | +0.70 ppfrom 5.50% | Dec 31, 2025 | SEC |
| Feb 5, 20262:04 PM ET | Capital International Investors | 13G/A | 1.20%1.19M shares | −6.20 ppfrom 7.40%Below 5% | Jan 30, 2026 | SEC |
| Nov 14, 202512:26 PM ET | Orbis Investment Management Ltdand 1 other | 13G | 5.50%4.97M shares | New | Sep 30, 2025 | SEC |
| Nov 4, 20254:48 PM ET | ARK Investment Management LLCand 1 otherSuperinvestorARK Invest | 13G/A | 10.76%9.79M shares | −1.09 ppfrom 11.85% | Sep 30, 2025 | SEC |
| Jul 17, 20257:44 PM ET | BlackRock, Inc. | 13G | 6.90%5.93M shares | New | Jun 30, 2025 | SEC |
| May 14, 202510:52 AM ET | ARK Investment Management LLCand 1 otherSuperinvestorARK Invest | 13G/A | 11.85%10.2M shares | +1.34 ppfrom 10.51% | Mar 31, 2025 | SEC |
| May 13, 20255:53 PM ET | Capital International Investors | 13G/A | 7.40%6.33M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 202511:23 AM ET | ARK Investment Management LLCSuperinvestorARK Invest | 13G/A | 10.51%8.97M shares | +1.71 ppfrom 8.80% | Dec 31, 2024 | SEC |
| Jan 10, 20259:23 PM ET | ARK Investment Management LLCSuperinvestorARK Invest | 13G/A | 8.80%7.50M shares | – | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell CRISPR Therapeutics AG shares.
No Form 144 notices for CRISPR Therapeutics AG are on file.